US 11434304
Anti-CD38 antibodies
granted A61KA61K2039/505A61K47/6871
Quick answer
US patent 11434304 (Anti-CD38 antibodies) held by Takeda Pharmaceutical Company Limited expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K2039/505, A61K47/6871, A61P, A61P1/00